Sr Market Access Manager

Essential Job Duties
• Market Access Strategy
Own the Korea market access strategy and roadmap for the daVinci and Ion portfolio, aligned to
BU priorities and lifecycle needs (new indications, new technologies, and evidence milestones).
Monitor intelligence on the Market Access landscape, including competition access, healthcare
system changes, Health Technology Assessment (HTA) developments, and general trends in the
field. Execute Market Access plans based on local needs and strategy aligned with affiliate and
global aspirations. Additionally, implement and execute strategic Market Access frameworks—
such as payer engagement, negotiation, and objection handling—in close collaboration with the
Affiliate Management Team and cross-functional stakeholders.
Navigate and respond to the evolving healthcare policy landscape related to daVinci robotic-
assisted surgery and Ion robotic-assisted bronchoscopy, expanding patient access by developing
and executing fee model and reimbursement pricing strategies, and developing and managing
strategies to broaden patient access through private insurance channels.
Lead cross-functional alignment on access priorities, risks, timelines, and trade-offs; act as the
local access “go-to” expert for daVinci and Ion.
• nHTA and HTR Strategy & Execution
Lead development of nHTA strategy (route selection, positioning, comparator strategy,
endpoints, evidence requirements, and stakeholder plan).
Drive preparation and submission of nHTA dossiers and supporting materials, coordinating
internal & external stakeholders
Manage end-to-end nHTA execution: evidence gap assessment, submission planning, Q&A
responses, expert input, and meeting preparation.
Leads the full spectrum of the Health Technology Reassessment (HTR) process by collaborating
with internal and external stakeholders to develop strategies, analyze clinical evidence, and
prepare submission materials to ensure barrier-free market expansion of target indications.
• Reimbursement, Coverage & Coding Pathways
Lead strategy for securing and optimizing reimbursement and coverage (e.g., benefit category,
fee schedule positioning, procedure payment considerations, and hospital economics).
Develop Korea-specific pricing strategy aligned with clinical value, budget impact, and health
economic data analysis and prepare pricing narrative and justification packages to support
external pricing discussions and negotiation
Develop practical reimbursement tools and guidance for internal teams to support customer
discussions and adoption.
• Evidence Translation & Value Communication
Translate clinical evidence and health economic insights into
payer-ready value propositions for Korea (e.g., burden of disease,
pathway impact, resource use, outcomes, and system efficiency).
Partner with Clinical Affair and HEOR to shape local evidence
generation needs (RWE, registries, pathway studies) that directly support nHTA and
reimbursement decisions.
Ensure all value messages and materials are compliant and locally appropriate.
• Stakeholder Engagement (External & Internal)
Identify and establish relationships with key decision-makers for market access and actively
involve in the political landscape and appropriately participate in policy initiatives.
Build and maintain relationships with key external stakeholders including academic societies and
KOLs.
Support cross-functional engagement plans with RA, CA, Commercial, and GA to shape the policy
environment and reduce access barriers.
Represent Market Access in local governance forums and provide updates to Korea leadership
and relevant global/regional stakeholders.
• Healthcare policy & Market I…